LPH: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented

Product code LPH, “Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3358 (hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 565 clearances under LPH, 208 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LPH
Regulation
21 CFR 888.3358
Class
II
Panel
Orthopedic
Clearances
565
Most recent
Sep 23, 2026
Median review, last 2 years
169 days
Third-party review
Not eligible
Implant
Yes

What it covers

A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.

The identification in 21 CFR 888.3358, hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis. FDA gives LPH no definition of its own, so the regulation’s describes it.

FDA flags LPH devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K261453G7® Acetabular SystemZimmer BiometSep 23, 2026Traditional
K253630Mpact 3D Metal FoamMedacta International S.A.Aug 28, 2026Traditional
K254043TRIVANCE™ Hip StemGlobus Medical, Inc.Aug 4, 2026Traditional
K261624Omnifit® 20° Series I Insert;Omnifit® Crossfire® 10° Series II Insert; Constrained Acetabular Insert; Trident® Crossfire® 0° Polyethylene Insert; Trident ® Crossfire ® 10° Polyethylene Insert;System 12 Crossfire® 10° Insert; Trident® 0° Constrained Acetabular Insert; Trident® Constrained Acetabular Liner;Trident® All Poly Constrained Acetabular Insert; Crossfire® Eccentric Insert 10°; Artisan® Bone Plug;UHR® Universal Head Bipolar ComponentHowmedica Osteonics Corp., Dba Stryker OrthopaedicsJul 10, 2026Traditional
K243192iNSitu Lateralized Acetabular Liners, iNSitu Femoral Stems with Plasma Sprayed CPTi CoatingNextstep Arthopedix, LLCJun 5, 2026Traditional
K251270Taperloc® Complete Hip StemBiomet, Inc.May 19, 2026Traditional
K252623G7® Revision Acetabular SystemZimmer, Inc.Feb 4, 2026Traditional
K251043Mpact 3D Metal Implants Extension – DMLS TechnologyMedacta International S.A.Jan 28, 2026Traditional
K252067Velora Acetabular SystemRestor3D, Inc.Dec 5, 2025Traditional
K252846TaperSet™ Hip SystemShalby Advanced Technologies, Inc. Dba Consensus OrthopedicsNov 20, 2025Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 565 with a free account)

Clearances by year

208 LPH 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)8256
202512153
2024692
202310111
202214247
20218410
20207164
201922164
20189145
201712121
201610150
201518111
201420129
201311135
20122576
201116110

Who submits

70 applicants cleared a LPH device since 2011. 73% of the clearances went to applicants in United States, then Taiwan (6%), South Korea (5%) and Switzerland (5%). By type: Traditional 71%, Special 28% and Abbreviated 0%.

ApplicantClearances since 2011
Smith & Nephew, Inc.17
Corentec Co., Ltd.12
United Orthopedic Corporation10
Biomet, Inc.9
Zimmer, Inc.9
Lima Corporate S.P.A.8
Medacta International S.A.8
Encore Medical L.P.7

How FDA classifies it

Class II.

From 21 CFR 888.3358.

Standards

21 CFR 888.3358 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LPH clearances declared.

Ask about LPH

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LPH

What is FDA product code LPH?

Product code LPH, “Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3358 (hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 565 clearances under LPH, 208 of them since 2011.

How many 510(k) clearances are there under LPH?

FDA’s 510(k) database listed 565 clearances under LPH as of Oct 29, 2026, 208 of them decided since 2011; the most recent decision was Sep 23, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LPH 510(k)?

For the 21 LPH clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 169 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LPH clearances?

Since 2011: Smith & Nephew, Inc. (17), Corentec Co., Ltd. (12), United Orthopedic Corporation (10), Biomet, Inc. (9) and Zimmer, Inc. (9). 70 applicants have cleared a LPH device in that time.

Sources

  1. FDA product classification: LPH · Product Classification database
  2. 21 CFR 888.3358: Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LPH · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LPHGet an email when FDA clears, recalls or publishes guidance for LPH devices.

Know what FDA already cleared.